Peritoneal Tuberculosis Mimics Ovarian Cancer: A Case Report
Peritoneal tuberculosis is a form of abdominal and/or pelvic tuberculosis. This entity can sometimes imitate ovarian cancer clinically, and is accompanied by an increase of serum cancer antigen 125 (CA-125) level, which may make the differential diagnosis between the two diseases a challenge for clinicians. We report herein a case of a 49-year-old woman whose symptoms, signs, imaging and laboratory findings suggested ovarian cancer, and document the risk factors for the development of tuberculosis. Finally, the diagnosis of peritoneal tuberculosis can be obtained through further research and appropriate data analysis. The purpose of this case is to improve the medical community’s understanding of the importance of distinguishing peritoneal tuberculosis in patients with suspected ovarian cancer, so as to make accurate differential diagnosis and avoid subjecting patients to unnecessary surgery.
Siegel R, Naishadham D, Jemal A, 2013, Cancer Statistics 2013. CA Cancer J Clin, 63:11–30.
Jemal A, Bray F, Center MM, et al., 2011, Global Cancer Statistics. CA Cancer J Clin, 61:69–90.
World Health Organization, 2008, Estimated Global Cancer Morbidity, Mortality, Prevalence and Disability Adjusted Life Years (DALYs) in 2008. Available from: http://globocan.iarc.fr.
Ivo Campagnolo M, DOS Reis R, Fulgèncio de Oliveira V, et al., 2000, Pelvic Tuberculosis Simulating Ovarian Tumor. Rev Bras de Ginecol e Obstet. 22:525–8.
Sharma MP, Bhatia V, 2004, Abdominal Tuberculosis. Indian J Med Res, 120:305–5.
Flores Acosta CC, Vidal Gutierrez O, Saldivar Rodriguez D, et al., 2010, Peritoneal Tuberculosis as a Differential Diagnosis of Ovarian Cancer. Medicina Universitaria, 12:192–5.
Oge T, Ozalp SS, Yalcin OT, et al., 2012, Peritoneal Tuberculosis Mimicking Ovarian Cancer. Eur J Obstet Gynecol Reprod Biol, 162:105–8.
Sharma JB, Jain SK, Pushparaj M, et al., 2010, Abdomino-Peritoneal Tuberculosis Masquerading as Ovarian Cancer: A Retrospective Study of 26 Cases. Arch Gynecol Obstet, 282:643–8.
Assinigas W, Ojuela DL, 2006, Extrapulmonary Tuberculosis: A Review of 102 Cases in Pereira, Colombia. Biomedicine, 26.
World Health Organization, 2011, Global Tuberculosis Control. Geneva. World Health Organization.
Chaparo PE, Garcia I, Guerrero MI, et al., 2004, Situación de la tuberculosis en Colombia, 2002 [Situation of Tuberculosis in Colombia, 2002]. Biomedicine, 24:102–14.
Ulusoy AN, Karabicak I, Dicle K, et al., 2010, Peritoneal Tuberculosis in Premenopausal Patients with Elevated Serum CA 125. Arch Gynecol Obstet, 282:639–42.
Jason ES, Christopher WW, Angeles AA, et al., 2001, Mycobacterium bovis Peritonitis Mimicking Ovarian Cancer in a Young Woman. Clin Infect Dis, 33:e14–6.
Shy K, Dubinsky T, 1999, Is Color Doppler Ultrasound Useful in Diagnosing Ovarian Cancer? Clin Obstet Gynecol, 42:902–4.
Carlson KJ, Skates SJ, Singer DE, 1994, Screening for Ovarian Cancer. Ann Intern Med, 121:124.
Bourne TH, Campbell S, Reynolds KM, et al., 1993, Screening for Early Familial Ovarian Cancer with Transvaginal Ultrasonography and Colour Blood Flow Imagining. BMJ, 306:1025–7.
Karlan BY, Raffel LJ, Crvenkovic G, et al., 1993, A Multidisciplinary Approach to the Early Detection of Ovarian Carcinoma: Rationale, Protocol Design, and Early Results. Am J Obstet Gynecol, 169:494–6.
Menon U, Skates SJ, Lewis S, et al., 2005, Prospective Study Using the Risk of Ovarian Cancer Algorithm to Screen for Ovarian Cancer. J Clin Oncol, 23:7919–26.
Rustin G, Van der Burg M, Berek J, 1993, Tumor Markers. Annals of Oncology, 4:71–7.
Grover R, Dhir V, Aneja R, et al., 2006, Severe Infections Following Leflunomide Therapy for Rheumatoid Arthritis. Rheumatology (Oxford), 45:918–20.
Zamšynski J, Olejek A, Oleś E, et al., 2009, Peritoneal Tuberculosis Simulating Ovarian Cancer—Difficult Diagnosis. Two Case Reports. Pneumonia Allergen, 77:422–8.
Uzunkoy A, Harma M, Harma M, 2004, Diagnosis of Abdominal Tuberculosis: Experience from 11 Cases and Review of the Literature. World J Gastroenterol, 10:3647–9.
Carmona L, Hernández G, Vadillo C, et al., 2003, Patients with Rheumatoid Arthritis Have an Increased Risk of Tuberculosis. Rheumatism, 30:1436–9.
Hocevar A, Rozman B, Praprotnik S, et al., 2006, Leflunomide-Associated Tuberculosis? Rheumatology (Oxford), 45:228–9.
Wallis RS, Broder MS, Wong JY, et al., 2004, Granulomatous Infectious Diseases Associated with Tumor Necrosis Factor Antagonists. Clin Infect Dis, 38:1261–5.
Harris J, Keane J, 2010, How Tumour Necrosis Factor Blockers Interfere with Tuberculosis Immunity. Clin Exp Immunol, 161:1–9.
Blanco Peres JJ, Aranda Torres a, Pego Regosa JM, et al., 2010, Pulmonary Tuberculosis Associated to Adalimumab: A Study of 3 Cases. Arch. Bronconeumol, 46:203–5.
Agrawal S, Sharma A, 2007, Dual Mycobacterial Infection in the Setting of Leflunomide Treatment for Rheumatoid Arthritis. Ann Rheum Dis, 66:277.
Azevedo VF, Paiva E, Tosin T, et al., 2011, Splenic Tuberculosis in a Patient with Ankylosing Spondylitis Treated with Adalimumab. Reumatismo, 63:171–4.
Carmona L, Gómez-United JJ, Rodríguez-Valverde V, et al., 2005, Effectiveness of Recommendations to Prevent Reactivation of Potential Tuberculosis Infection in Patients Treated with Tumor Necrosis Factor Antagonists. Rheumatoid Arthritis, 52:1766–72.
Mota LM, Cruz BA, Brenol CV, et al., 2012, 2012 Brazilian Society of Rheumatology Consensus for the Treatment of Rheumatoid Arthritis. Rev Bras Reumatol, 52:152–74.
Golicki D, Newada M, Lis J, et al., 2012, Leflunomide in Monotherapy of Rheumatoid Arthritis: Meta-Analysis of Randomized Trials. Pol. Arch Med Wewn, 122:22–32.